Protease inhibitors for prevention of ERCP pancreatitis: can we afford the price of success?

The American journal of gastroenterology

Volumn 92, Issue 6, 1997, Pages 1067-1068

  Ziebert, J J ^a   Bjorkman, D J ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GABEXATE; PLACEBO; SERINE PROTEINASE INHIBITOR;

ARTICLE; COST; DRUG COST; ECONOMICS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; PANCREATITIS; TREATMENT OUTCOME;

CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; COSTS AND COST ANALYSIS; DRUG COSTS; GABEXATE; HUMANS; PANCREATITIS; PLACEBOS; SERINE PROTEINASE INHIBITORS; TREATMENT OUTCOME;

EID: 0031156786     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)